Allan Jacobson's most recent trade in PTC Therapeutics Inc was a trade of 4,000 Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 4,000 | 21,451 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,475 | 3,475 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 7,900 | 25,351 (0%) | 0% | 18.0 | 142,279 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 7,900 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 24 Nov 2025 | 6,299 | 23,750 (0%) | 0% | 11.2 | 70,738 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 6,299 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 6,100 | 23,551 (0%) | 0% | 18.0 | 109,861 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 80.15 per share. | 24 Nov 2025 | 6,100 | 17,451 (0%) | 0% | 80.2 | 488,915 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 6,100 | 7,900 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 24 Nov 2025 | 5,701 | 23,152 (0%) | 0% | 11.2 | 64,022 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 80.13 per share. | 24 Nov 2025 | 5,701 | 17,451 (0%) | 0% | 80.1 | 456,821 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 5,701 | 6,299 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 83.38 per share. | 24 Nov 2025 | 3,502 | 19,389 (0%) | 0% | 83.4 | 291,997 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 83.93 per share. | 24 Nov 2025 | 2,510 | 18,976 (0%) | 0% | 83.9 | 210,664 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 82.58 per share. | 24 Nov 2025 | 2,460 | 22,891 (0%) | 0% | 82.6 | 203,147 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 82.63 per share. | 24 Nov 2025 | 2,264 | 21,486 (0%) | 0% | 82.6 | 187,074 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 84.47 per share. | 24 Nov 2025 | 1,238 | 18,151 (0%) | 0% | 84.5 | 104,574 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 84.45 per share. | 24 Nov 2025 | 1,125 | 17,851 (0%) | 0% | 84.4 | 95,006 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 85.32 per share. | 24 Nov 2025 | 700 | 17,451 (0%) | 0% | 85.3 | 59,724 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 85.24 per share. | 24 Nov 2025 | 400 | 17,451 (0%) | 0% | 85.2 | 34,096 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 03 Oct 2025 | 12,000 | 29,451 (0%) | 0% | 30.9 | 370,320 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 03 Oct 2025 | 12,000 | 17,451 (0%) | 0% | 65 | 780,000 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 50.15 per share. | 28 Aug 2025 | 1,667 | 17,451 (0%) | 0% | 50.1 | 83,600 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 04 Mar 2025 | 1,230 | 19,118 (0%) | 0% | 51.5 | 63,370 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 20,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 16,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 22 Jan 2024 | 10,000 | 12,348 (0%) | 0% | 27.4 | 273,804 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jacobson Allan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.05 per share. | 22 Jan 2024 | 10,000 | 22,348 (0%) | 0% | 27.1 | 270,500 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 23,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.85 per share. | 11 May 2023 | 23,000 | 35,348 (0%) | 0% | 10.9 | 249,550 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 54.78 per share. | 11 May 2023 | 19,040 | 16,308 (0%) | 0% | 54.8 | 1,043,074 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 56.35 per share. | 11 May 2023 | 2,860 | 13,448 (0%) | 0% | 56.4 | 161,169 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Sale of securities on an exchange or to another person at price $ 56.99 per share. | 11 May 2023 | 1,100 | 12,348 (0%) | 0% | 57.0 | 62,687 | Common Stock |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 12,348 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 8,348 (0%) | 0% | 0 | Common Stock |